Wakefit Innovations IPO Review 2025 — Price Band, GMP, Allotment & Analysis
Wakefit Innovations IPO – Price Band, GMP Trend, Subscription, Allotment & Detailed Review (2025)
Prepared by Money Bells Global Research Services Pvt. Ltd. (SEBI Registered Research Analyst – INH100009901)
📩 Get Premium IPO & Equity Research Reports
Create your Moneybells account and get instant access to research reports directly in your dashboard.
👉 Sign Up & Access Reports📘 Table of Contents
1. Wakefit Innovations IPO – Summary
Wakefit Innovations Limited is one of India's leading D2C (Direct-to-Consumer) brands in the home and sleep solutions category. The company manufactures and sells mattresses, furniture, and home products through online and offline channels.
2. Wakefit Innovations IPO Details
| Detail | Information |
|---|---|
| IPO Open Date | 8 December 2025 |
| IPO Close Date | 10 December 2025 |
| Price Band | ₹185 – ₹195 |
| Total Issue Size | ₹1,288.89 crore |
| Fresh Issue | ₹377.18 crore (approx.) |
| Offer for Sale (OFS) | ₹911.71 crore (approx.) |
| Face Value | ₹1 per share |
| Lot Size | 76 shares |
| Minimum Investment | ₹14,820 |
| Issue Type | Book Built |
| Listing Exchange | BSE & NSE |
| Expected Listing Date | 15 December 2025 |
3. Company Overview
Wakefit manufactures mattresses, furniture, sofas, home-decor items, and sleep accessories. It follows a vertically integrated manufacturing and logistics model, giving it strong control over product pricing and quality.
Products include:
- Mattresses & Sleep Solutions
- Furniture – Beds, Sofas, Tables, Wardrobes
- Home Décor & Utility Products
4. Financial Performance
| Metric | FY23 | FY24 | FY25 (Estimated) |
|---|---|---|---|
| Revenue | ₹825 crore | ₹1017 crore | ₹1294 crore (H1 / Estimated) |
| Profit / Loss | Loss | Profit improving | Positive trend |
| EBITDA Margin | 4% | 6% | 8% |
| Debt-Equity | 0.48 | 0.42 | 0.35 |
5. Strengths
- Strong D2C brand presence
- Large diversified product portfolio
- Growing offline store expansion
- Improving profitability
- Cost-efficient supply chain & logistics
6. Risks & Challenges
- Highly competitive furniture & mattress market
- Thin margins in furniture segment
- Consumer discretionary demand risk
- High logistics and manufacturing costs
7. Grey Market Premium (GMP)
IPO GMP indicates moderate listing expectations. GMP fluctuates according to market sentiment and does not guarantee listing gains.
| Date | GMP (₹) |
|---|---|
| Day 1 | ₹20 – ₹30 |
| Day 2 | ₹25 – ₹40 |
| Day 3 | ₹30 – ₹45 |
8. Subscription Status
Subscription figures will be updated during the IPO window. Early expectations indicate strong interest from institutional investors.
9. Allotment Status
Allotment status will be available on the registrar's website after allotment finalisation.
🔗 Check Wakefit Innovations IPO Allotment Status
10. Basis of Allotment
Basis of Allotment depends on category-wise subscription. If oversubscribed, retail allotment may occur via lottery.
11. Review & Recommendation
Wakefit’s rapidly growing brand presence, improving financials, and expanding offline presence make it attractive for long-term investors. Short-term listing gains depend on GMP and subscription levels.
Short-Term View: Moderate potential for listing gains.
Long-Term View: Strong business model with scalable growth opportunity.
.jpg)